Concord Medical Services Holdings Limited (CCM) Stock Price & Analysis
Concord Medical Services Holdings Limited (CCM) — MoonshotScore 26/100 (Weak band), calculated Nov 18, 2026. Price $3.41 (-5.36%), as of the Nov 19, 2026 trading session; market cap $14.8M.
Educational signal · not a buy or sell recommendation · How to read this
Concord Medical Services Holdings Limited · CCM · NYSE
Concord Medical Services Holdings Limited operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company provides a range of services including radiotherapy, diagnostic imaging, and clinical support.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Concord Medical Services Holdings (CCM)
WeakWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
A strong balance sheet and durable growth, but an expensive valuation. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Average; Financial Safety: Fortress; Valuation: Bubble; Growth Durability: Growing; Momentum: Quiet.
Earnings yield is the main valuation drag relative to sector peers.
- quarterly revenue CN¥255M (Q4 FY2025, quarter ended Dec 31, 2025)
- Altman Z -1.19 · Piotroski F 6
- ROE 5.2% · ROA -1.7% · current ratio 0.48
Holding back: a rich price
Helping: balance-sheet strength, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 30 | Weak | |
| 26 | Weak | |
| 26 | Weak | |
| 26 | Weak | |
| 26 | Weak | |
| 26 | Weak |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $3.41 | |
| Change on the day | -5.36% | |
| 52-week range | $2.79 – $6.80 | |
| Market capitalisation | $14.8M | — |
| Shares traded on the day | 18.3K |
Price & events
Other perspectives
Council score for Concord Medical Services Holdings (CCM): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
3 lenses, 3 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 19, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 19, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Concord Medical Services Holdings (CCM), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Concord Medical Services Holdings Limited (CCM) is listed on NYSE. It employs 610 people and is led by Jianyu Yang. In Q4 FY2025 it reported revenue of CN¥255M and net income of -CN¥64M. The market values it at $14.8M.
What do the latest results show for Concord Medical Services Holdings (CCM)?
Short answer · as of
The most recent reported quarter, Q4 FY2025, carried revenue of CN¥255M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2025 | CN¥255M | -CN¥64M | -CN¥444.60 (diluted) |
| Q3 FY2025 | CN¥130M | -CN¥33M | -CN¥225.60 (diluted) |
| Q2 FY2025 | CN¥100M | -CN¥14M | -CN¥94.50 (diluted) |
| Q1 FY2025 | CN¥100M | -CN¥14M | -CN¥94.50 (diluted) |
What are the financial strengths and risks for Concord Medical Services Holdings (CCM)?
Short answer
The MoonshotScore pillars rate balance-sheet strength, durable growth as strengths. What is holding it back is a rich price. The distress and quality screens read Altman Z -1.19 · Piotroski F 6. Trailing ratios: ROE 5.2% · ROA -1.7% · current ratio 0.48.
What should you watch next at Concord Medical Services Holdings (CCM)?
Short answer · as of
Analyst estimates on file carry FY2026 revenue $440.38M · EPS -18.25 · 1 analysts.
What the records here don't tell us
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
- The newest quarter held here (Q4 FY2025) was filed Apr 29, 2026 — 6 months ago.
Checked against the records this page reads, on the dates shown above.
How does Concord Medical Services Holdings compare with its peers?
Short answer
Concord Medical Services Holdings's score ranks 12th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $34.35 Nov 19, 2026 | $1.32B | 93 5-pillar Nov 18, 2026 | |
| $8.91 Nov 19, 2026 | $1.22B | 92 5-pillar Nov 18, 2026 | |
| $6.43 Nov 19, 2026 | $88.0M | 73 5-pillar Nov 18, 2026 | |
| $34.09 Nov 19, 2026 | $1.20B | 68 5-pillar Nov 18, 2026 | |
| $3.90 Nov 19, 2026 | $289M | 59 5-pillar Nov 18, 2026 | |
| $1.61 Nov 19, 2026 | $227M | 52 5-pillar Nov 18, 2026 | |
| $1.05 Nov 19, 2026 | $7.01M | 43 5-pillar Nov 18, 2026 | |
| $0.84 Nov 19, 2026 | $27.3M | 39 5-pillar Nov 18, 2026 | |
| $4.15 Nov 19, 2026 | $33.5M | 33 5-pillar Nov 18, 2026 | |
| $0.65 Nov 19, 2026 | $48.4M | 33 5-pillar Nov 18, 2026 | |
| $1.86 Nov 19, 2026 | $385M | 31 5-pillar Nov 18, 2026 | |
| Concord Medical Services Holdings (CCM) — this page | $3.41 | $14.8M | 26 |
| $8.65 Nov 19, 2026 | $1.23B | 23 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Revenue estimate
- $440.38M
- EPS estimate
- $-18.25
Measured against a quoted price of $3.41 (as of Nov 19, 2026).
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held CCM in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported CCM in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About Concord Medical Services Holdings (CCM)
These answers are editorial: 1 of these 9 answers is drawn from the CCM research dossier (written Mar 15, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for CCM?
CCM carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is CCM a good stock to buy?
Stock Expert AI does not rate CCM buy, sell or hold. Concord Medical Services Holdings Limited carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the CCM stock price today?
The last price recorded for Concord Medical Services Holdings Limited (CCM), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What do analysts say about CCM stock?
There is no analyst consensus available in the provided data. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.
What are the key factors to evaluate for CCM?
Concord Medical Services Holdings Limited (CCM) holds a MoonshotScore in the low range. These techniques offer more precise and effective cancer treatment, attracting patients seeking advanced care. Not financial advice.
How frequently does CCM data refresh on this page?
CCM's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven CCM's recent stock price performance?
Concord Medical Services Holdings Limited (CCM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established network of radiotherapy and diagnostic imaging centers in China. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CCM overvalued or undervalued right now?
Concord Medical Services Holdings Limited (CCM) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of CCM?
Fractional-share availability for Concord Medical Services Holdings Limited (CCM) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 18 figures on this page — 7 from Financial Modeling Prep (FMP), 9 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com